Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-25-009556)

Filing Details

Accession Number:: 0001127602-25-009556
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-14 20:53:44
Reporting Period:: 2025-03-14

Filing Date:: 2025-03-14
Accepted Time:: 2025-03-14 20:53:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061983	Cytokinetics Inc	CYTK	Pharmaceutical Preparations (2834)	943291317

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1852129	Andrew Callos	350 Oyster Point Blvd South San Francisco CA 94080	Evp, Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-03-14	100	$23.26	37,763	No	4	M	Direct
Common Stock	Disposition	2025-03-14	100	$45.00	37,663	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (Right to Buy)	Disposition	2025-03-14	100	$0.00	100	$23.26

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
149,900	2022-03-31	2031-03-31	No	4	M	Direct

Footnotes

Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer.